Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
Grifols

Grifols (GRFS US)

30
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols SA
02 Apr 2025 21:30

Blood, Sweat, and Bids: Grifols Draws Renewed Interest from Brookfield

​Brookfield's renewed interest in Grifols signals confidence in its turnaround, with strengthened financials and potential for improved future...

Share
16 Mar 2025 22:45

Liquid Universe of European Ordinary and Preferred Shares: March '25 Report

​European share-price spreads have generally tightened since mid-February, with volatility; Carlsberg B discount at 5-year record low,...

Share
16 Feb 2025 23:12

Liquid Universe of European Ordinary and Preferred Shares: February'25 Report

Since mid-January, share-price spreads have generally widened across European liquid universe of ordinary and preferred shares (11 have widened, 3...

Share
bullishCSL Ltd
12 Feb 2025 00:30

CSL Ltd (CSL AU): Weak Vaccine Sales Affect H1FY25 Performance; FY25 Guidance Maintained

​CSL Ltd's H1FY25 net profit rises 6% YoY to $2.01B, missing estimates. Revenue is up 5% YoY to $8.48B. FY25 profit guidance reaffirmed at $3.2...

Logo
362 Views
Share
bullishRoche Holding
16 Jan 2025 13:18

Liquid Universe of European Ordinary and Preferred Shares: January'25 Report

Since mid-December, share-price spreads have generally tightened across European liquid universe of ordinary and preferred shares (8 have widened,...

Share
x